Are Home Genome Tests a Step Away from Eugenics?
By Annalee Newitz,
AlterNet
| 11. 29. 2007
A company called 23andme.com launched last week and got wads of media attention for being the first user-friendly Web site devoted to home genomics tests and analysis. For just $1,000, the company will take a swab of your cheek, sequence your genome, and tell you a bunch of things about how you fit into the Family of Humanity. They'll also allegedly give you nifty details about yourself, such as whether you have athletic abilities or a propensity for disease.
And 23andme is just the beginning. Another company called DeCode offers a similar service called DeCodeMe, and more are sure to follow. People are desperate to understand themselves, and so they turn to genetics as if it were a self-help manual instead of a still poorly understood science. While there are many theories about how genetic expression works on our personalities and health, there are few solid facts. Some tests, such as those for various kinds of developmental disabilities, have provable results. But many genetic tests, like those 23andme claim can reveal "athletic ability" are the biotech version of snake oil...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...